Jupiter Neurosciences(JUNS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

JUNS Jupiter Neurosciences

Trading 03-16 11:32:18 EDT

0.4001

-0.0227

-5.37%

High0.4401	Low0.4000	Vol93.47K
Open0.4400	D1 Closing0.4228	Amplitude9.48%
Mkt Cap13.77M	Tradable Cap5.95M	Total Shares34.43M
T/O38.91K	T/O Rate0.63%	Tradable Shares14.88M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"JUNS","market":"US","secType":"STK","nameCN":"Jupiter Neurosciences","latestPrice":0.4001,"timestamp":1773674890664,"preClose":0.4228,"halted":0,"volume":93468,"delay":0,"changeRate":-0.053689687795648054,"floatShares":14876300,"shares":34426355,"eps":-0.230265,"marketStatus":"Trading","change":-0.0227,"latestTime":"03-16 11:32:18 EDT","open":0.44,"high":0.4401,"low":0.4,"amount":38909.81428296,"amplitude":0.094844,"askPrice":0.4304,"askSize":100,"bidPrice":0.4,"bidSize":3200,"shortable":3,"etf":0,"ttmEps":-0.230265,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1773691200000},"marketStatusCode":2,"adr":0,"listingDate":1733202000000,"exchange":"NASDAQ","adjPreClose":0.4228,"preHourTrading":{"tag":"盘前","latestPrice":0.44,"preClose":0.4228,"latestTime":"09:25 EDT","volume":2577,"amount":1130.16247134,"timestamp":1773667507827,"change":0.0172,"changeRate":0.040681,"amplitude":0.018921},"postHourTrading":{"tag":"盘后","latestPrice":0.4499,"preClose":0.4228,"latestTime":"19:59 EDT","volume":3265,"amount":1444.848,"timestamp":1773446355959,"change":0.0271,"changeRate":0.064096,"amplitude":0.064333},"volumeRatio":1.173469},"requestUrl":"/m/hq/s/JUNS/wiki","defaultTab":"wiki","newsList":[{"id":"2616332221","title":"Jupiter Neurosciences to Present at BIO Investment and Growth Summit 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2616332221","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616332221?lang=en_us&edition=fundamental","pubTime":"2026-03-02 21:02","pubTimestamp":1772456561,"startTime":"0","endTime":"0","summary":"Jupiter Neurosciences Inc.  said it will participate in the BIO Investment and Growth Summit 2026, hosted by the Biotechnology Innovation Organization , on March 2–3, 2026 in Miami Beach, Florida, with its corporate presentation scheduled for March 2, 2026 at 2:30 PM.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260302:nNDL3mMh4V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","IE00B64PRP62.GBP","BK4585","IE00B3QW5Z07.USD","LU2210149790.SGD","NDAQ","IE00BGHQF748.EUR","SG9999014021.USD","IE00BKPKM429.USD","BK4112","JUNS","LU0314104364.USD","SG9999014013.SGD","SG9999014005.SGD","LU2210150020.SGD","LU2095319765.USD","SG9999014039.USD","BK4007"],"gpt_icon":0},{"id":"2614589810","title":"Jupiter Neurosciences Receives Nasdaq Deficiency Notices, Faces Delisting","url":"https://stock-news.laohu8.com/highlight/detail?id=2614589810","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614589810?lang=en_us&edition=fundamental","pubTime":"2026-02-28 06:25","pubTimestamp":1772231140,"startTime":"0","endTime":"0","summary":"Jupiter Neurosciences, Inc. ( ($JUNS) ) has provided an update. On February 26, 2026, Jupiter Neurosciences disclosed it had received two Nasdaq de...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/jupiter-neurosciences-receives-nasdaq-deficiency-notices-faces-delisting?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/jupiter-neurosciences-receives-nasdaq-deficiency-notices-faces-delisting?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NQmain","BK4007","JUNS"],"gpt_icon":0},{"id":"2614867662","title":"Nasdaq Flags Jupiter Neurosciences for Bid Price and Market Value Listing Deficiencies","url":"https://stock-news.laohu8.com/highlight/detail?id=2614867662","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614867662?lang=en_us&edition=fundamental","pubTime":"2026-02-28 05:33","pubTimestamp":1772228032,"startTime":"0","endTime":"0","summary":"Jupiter Neurosciences Inc. said it received Nasdaq notices that it is out of compliance with continued listing rules after its shares traded below the $1.00 minimum bid price for 30 consecutive business days and its market value of listed securities fell below the $35 million threshold over the same period. The company has until Aug. 25, 2026 to regain compliance with each requirement or potentially face delisting, though its stock will continue trading on the Nasdaq Capital Market in the meantime.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jupiter Neurosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securitie","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260227:nNDL3dZ8ST:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JUNS","BK4007"],"gpt_icon":0},{"id":"2614870400","title":"Jupiter Neurosciences to Present Clinical and Commercial Progress at Mar-a-Lago Investor Dinner","url":"https://stock-news.laohu8.com/highlight/detail?id=2614870400","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614870400?lang=en_us&edition=fundamental","pubTime":"2026-02-25 21:31","pubTimestamp":1772026267,"startTime":"0","endTime":"0","summary":"Jupiter Neurosciences to Present Clinical and Commercial Progress at Mar-a-Lago Investor Dinner               Jupiter Neurosciences Inc. said its senior management has been invited to present clinical","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260225:nNDL4vC40h:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014021.USD","SG9999014039.USD","BK4588","BK4007","IE00BGHQF748.EUR","BK4112","LU2210150020.SGD","IE00B64PRP62.GBP","LU2095319765.USD","LU2210149790.SGD","IE00B3QW5Z07.USD","IE00BKPKM429.USD","JUNS","SG9999014013.SGD","SG9999014005.SGD","LU0314104364.USD","NDAQ","BK4585"],"gpt_icon":0},{"id":"2613780193","title":"Jupiter Neurosciences Delays Yorkville Note Installments to April 1, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2613780193","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613780193?lang=en_us&edition=fundamental","pubTime":"2026-02-23 22:30","pubTimestamp":1771857008,"startTime":"0","endTime":"0","summary":"Jupiter Neurosciences said it has amended its financing arrangement with Yorkville to delay the start of monthly installment payments to April 1, 2026, while keeping the overall $6.0 million financing economics unchanged. The company said the update is intended to better align its capital needs with progress on its Phase II Parkinson’s program and the commercialization of Nugevia.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jupiter Neurosciences Inc. published the original content used to generate this news brief via GlobeNewswire  on February 23, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260223:nNDL96PgvQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","IE00B64PRP62.GBP","LU0314104364.USD","IE00BKPKM429.USD","LU2095319765.USD","NDAQ","IE00B3QW5Z07.USD","SG9999014013.SGD","BK4588","BK4585","SG9999014021.USD","SG9999014039.USD","SG9999014005.SGD","LU2210150020.SGD","BK4112","LU2210149790.SGD","JUNS","IE00BGHQF748.EUR"],"gpt_icon":0},{"id":"2613218169","title":"Jupiter Neurosciences Amends Yorkville Financing Agreement Terms","url":"https://stock-news.laohu8.com/highlight/detail?id=2613218169","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613218169?lang=en_us&edition=fundamental","pubTime":"2026-02-21 06:31","pubTimestamp":1771626676,"startTime":"0","endTime":"0","summary":"The latest update is out from Jupiter Neurosciences, Inc. ( ($JUNS) ). On February 20, 2026, Jupiter Neurosciences, Inc. amended the terms of its f...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/jupiter-neurosciences-amends-yorkville-financing-agreement-terms?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/jupiter-neurosciences-amends-yorkville-financing-agreement-terms?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","JUNS"],"gpt_icon":0},{"id":"2613290209","title":"Jupiter Neurosciences Amends Yorkville Convertible Notes to Delay Monthly Payments Until April 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2613290209","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613290209?lang=en_us&edition=fundamental","pubTime":"2026-02-21 06:09","pubTimestamp":1771625348,"startTime":"0","endTime":"0","summary":"Jupiter Neurosciences Inc. said it entered into an omnibus amendment on Feb. 20, 2026 with YA II PN, LTD  to modify the monthly payment terms of its amended and restated convertible promissory notes issued under a standby equity purchase agreement. The amendment delays the start of monthly installment payments to April 1, 2026, shifts payments to a variable schedule, and updates provisions governing advance notices, while allowing the company to satisfy installments in cash, via advance repayment, or a combination of both.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jupiter Neurosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system opera","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260220:nNDL5Y3qBm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JUNS","BK4007"],"gpt_icon":0},{"id":"2606790652","title":"Jupiter Neurosciences Inc - Announces Strategic Initiative for Glp-1 Users","url":"https://stock-news.laohu8.com/highlight/detail?id=2606790652","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606790652?lang=en_us&edition=fundamental","pubTime":"2026-01-28 19:00","pubTimestamp":1769598040,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260128:nFWN3YT0RT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["JUNS","BK4007"],"gpt_icon":0},{"id":"2606403790","title":"Jupiter Neurosciences Expands Nugevia™ Addressable Market with Focus on GLP-1 Users","url":"https://stock-news.laohu8.com/highlight/detail?id=2606403790","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606403790?lang=en_us&edition=fundamental","pubTime":"2026-01-28 19:00","pubTimestamp":1769598000,"startTime":"0","endTime":"0","summary":"Nugevia supports metabolic, mitochondrial, and neuroinflammatory biology impacted by GLP-1-driven weight loss Jupiter, Florida, Jan.  28, 2026  (GLOBE NEWSWIRE) -- Jupiter Neurosciences, Inc. (NASDAQ:","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/01/28/3227379/0/en/Jupiter-Neurosciences-Expands-Nugevia-Addressable-Market-with-Focus-on-GLP-1-Users.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4135","CNS","GLP","BK4144","JUNS","BK4007","BK4590"],"gpt_icon":0},{"id":"2606735178","title":"Jupiter Neurosciences to Present at DealFlow Discovery Conference in Atlantic City","url":"https://stock-news.laohu8.com/highlight/detail?id=2606735178","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606735178?lang=en_us&edition=fundamental","pubTime":"2026-01-27 23:45","pubTimestamp":1769528715,"startTime":"0","endTime":"0","summary":"Jupiter Neurosciences, Inc. will participate in the 3rd Annual DealFlow Discovery Conference, taking place January 28-29, 2026, at The Borgata Hotel, Casino & Spa in Atlantic City, NJ. Chairman and CEO Christer Rosén will deliver a company presentation and be available for one-on-one investor meetings throughout the event.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jupiter Neurosciences Inc. published the original content used to generate this news brief via ACCESS Newswire  on January 27, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260127:nNDL3p707L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JUNS","BK4007"],"gpt_icon":0},{"id":"2593446321","title":"Jupiter Neurosciences Secures $1.86 Million Second Tranche Financing from Yorkville","url":"https://stock-news.laohu8.com/highlight/detail?id=2593446321","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593446321?lang=en_us&edition=fundamental","pubTime":"2025-12-24 06:30","pubTimestamp":1766529009,"startTime":"0","endTime":"0","summary":"Jupiter Neurosciences Inc. has entered into a financing arrangement under a Standby Equity Purchase Agreement  with Yorkville. On December 23, 2025, the company received $1,860,000 as the second tranche of a pre-paid advance, following stockholder approval. In exchange, Jupiter issued a second convertible promissory note to Yorkville. The agreement allows Jupiter, at its discretion, to direct Yorkville to purchase additional shares of its common stock up to a defined maximum amount, subject to the terms of the SEPA. The securities are being issued in reliance on an exemption from registration under the Securities Act.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jupiter Neurosciences Inc. published the original content used to genera","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251223:nNDL6vzJF1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","JUNS"],"gpt_icon":0},{"id":"2593458718","title":"Jupiter Neurosciences Inc. Held Annual Shareholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2593458718","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593458718?lang=en_us&edition=fundamental","pubTime":"2025-12-23 05:31","pubTimestamp":1766439077,"startTime":"0","endTime":"0","summary":"Jupiter Neurosciences Inc. held its 2025 Annual Meeting of Stockholders on December 19, 2025. Stockholders approved the Jupiter Neurosciences Inc. 2025 Equity Incentive Plan and an amendment to the company's certificate of incorporation to increase the number of authorized shares of common stock from 125,000,000 to 500,000,000.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jupiter Neurosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 22, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251222:nNDL29Gq6Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JUNS","BK4007"],"gpt_icon":0},{"id":"2588066274","title":"Jupiter Neurosciences to Present at NobleCon21 Emerging Growth Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2588066274","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588066274?lang=en_us&edition=fundamental","pubTime":"2025-12-03 05:15","pubTimestamp":1764710158,"startTime":"0","endTime":"0","summary":"Jupiter Neurosciences Inc. will participate in the Noble Capital Markets' 21st Annual Emerging Growth Equity Conference  on December 2-3, 2025, in Boca Raton, Florida. The company's management team will present at the event and be available for one-on-one meetings with members of the investment community.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jupiter Neurosciences Inc. published the original content used to generate this news brief via Newsfile  on December 02, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251202:nNDL7tcx8W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JUNS","BK4007"],"gpt_icon":0},{"id":"2586930162","title":"BRIEF-Jupiter Neurosciences Files Rospectus Related To Resale Of Up To 10 Million Shares Of Our Common Stock By Selling Stockholder","url":"https://stock-news.laohu8.com/highlight/detail?id=2586930162","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586930162?lang=en_us&edition=fundamental","pubTime":"2025-11-27 06:32","pubTimestamp":1764196340,"startTime":"0","endTime":"0","summary":"BRIEF-Jupiter Neurosciences Files Rospectus Related To Resale Of Up To 10 Million Shares Of Our Common Stock By Selling StockholderNov 26  - Jupiter Neurosciences Inc JUNS.O:JUPITER NEUROSCIENCES INC - FILES ROSPECTUS RELATED TO RESALE OF UP TO 10 MILLION SHARES OF OUR COMMON STOCK BY SELLING STOCKHOLDERSource text: [ID:n0001493152-25-025204]Further company coverage: JUNS.O ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251126:nFWN3X20LZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JUNS","BK4007"],"gpt_icon":0},{"id":"2586036293","title":"Jupiter Neurosciences Inc - Files Rospectus Related to Resale of up to 10 Mln Shares of Our Common Stock by Selling Stockholder","url":"https://stock-news.laohu8.com/highlight/detail?id=2586036293","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586036293?lang=en_us&edition=fundamental","pubTime":"2025-11-27 06:30","pubTimestamp":1764196228,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251126:nFWN3X20LZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["JUNS","BK4007"],"gpt_icon":0},{"id":"2585157743","title":"Jupiter Neurosciences Issues Amended SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2585157743","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585157743?lang=en_us&edition=fundamental","pubTime":"2025-11-21 05:06","pubTimestamp":1763672782,"startTime":"0","endTime":"0","summary":"Jupiter Neurosciences Inc. has filed an amendment to its previously issued Form 8-K report to update and correct information in Item 1.01. The amended report, filed on November 19, 2025, modifies details originally disclosed in the October 27, 2025 filing.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jupiter Neurosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 20, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251120:nNDL7wsBZZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","JUNS"],"gpt_icon":0},{"id":"2581706248","title":"Jupiter Neurosciences price target lowered to $25 from $30 at Greenridge","url":"https://stock-news.laohu8.com/highlight/detail?id=2581706248","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581706248?lang=en_us&edition=fundamental","pubTime":"2025-11-06 04:15","pubTimestamp":1762373754,"startTime":"0","endTime":"0","summary":"Greenridge analyst William Gregozeski lowered the firm’s price target on Jupiter Neurosciences (JUNS) to $25 from $30 and keeps a Buy rating on the...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/jupiter-neurosciences-price-target-lowered-to-25-from-30-at-greenridge-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/jupiter-neurosciences-price-target-lowered-to-25-from-30-at-greenridge-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["JUNS"],"gpt_icon":0},{"id":"2581247778","title":"Jupiter receives FDA clearance of IND application to initiate Phase 2 trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2581247778","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581247778?lang=en_us&edition=fundamental","pubTime":"2025-11-05 21:36","pubTimestamp":1762349790,"startTime":"0","endTime":"0","summary":"Jupiter Neurosciences (JUNS) announced that the U.S. Food and Drug Administration, FDA, has cleared its Investigational New Drug, IND, application ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/jupiter-receives-fda-clearance-of-ind-application-to-initiate-phase-2-trial-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/jupiter-receives-fda-clearance-of-ind-application-to-initiate-phase-2-trial-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","JUNS"],"gpt_icon":0},{"id":"2581778994","title":"BRIEF-Jupiter Neurosciences Receives FDA Clearance of IND Application to Initiate Phase 2a Clinical Trial of JOTROL in Parkinson’s Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2581778994","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581778994?lang=en_us&edition=fundamental","pubTime":"2025-11-05 21:32","pubTimestamp":1762349530,"startTime":"0","endTime":"0","summary":"BRIEF-Jupiter Neurosciences Receives FDA Clearance of IND Application to Initiate Phase 2a Clinical Trial of JOTROL in Parkinson’s DiseaseNov 5 (Reuters) - Jupiter Neurosciences Inc JUNS.O:JUPITER NEU","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251105:nTUA1CWBXN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","JUNS"],"gpt_icon":0},{"id":"2581077869","title":"Jupiter Neurosciences Inc - Expects Trial Enrollment to Begin in Early 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2581077869","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581077869?lang=en_us&edition=fundamental","pubTime":"2025-11-05 21:30","pubTimestamp":1762349400,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251105:nTUA1CWBXN:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["JUNS","BK4007"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.jupiterneurosciences.com","stockEarnings":[{"period":"1week","weight":0.0925},{"period":"1month","weight":-0.3069},{"period":"3month","weight":-0.6225},{"period":"6month","weight":-0.7218},{"period":"1year","weight":-0.3048},{"period":"ytd","weight":-0.5855}],"compareEarnings":[{"period":"1week","weight":-0.015},{"period":"1month","weight":-0.0429},{"period":"3month","weight":-0.0286},{"period":"6month","weight":0.0074},{"period":"1year","weight":0.2011},{"period":"ytd","weight":-0.0288}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"exchange":"NASDAQ","name":"Jupiter Neurosciences","nameEN":"Jupiter Neurosciences"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Jupiter Neurosciences(JUNS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Jupiter Neurosciences(JUNS) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Jupiter Neurosciences,JUNS,Jupiter Neurosciences股票,Jupiter Neurosciences股票老虎,Jupiter Neurosciences股票老虎国际,Jupiter Neurosciences行情,Jupiter Neurosciences股票行情,Jupiter Neurosciences股价,Jupiter Neurosciences股市,Jupiter Neurosciences股票价格,Jupiter Neurosciences股票交易,Jupiter Neurosciences股票购买,Jupiter Neurosciences股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Jupiter Neurosciences(JUNS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Jupiter Neurosciences(JUNS) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction